Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

This study has been completed.
Sponsor:
Information provided by:
Hopital du Sacre-Coeur de Montreal
ClinicalTrials.gov Identifier:
NCT00433784
First received: February 8, 2007
Last updated: August 20, 2012
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2006
  Estimated Primary Completion Date: No date given